Last reviewed · How we verify
Identification of Circulating Tumor Cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Identification of Circulating Tumor Cells (Identification of Circulating Tumor Cells) — Fondation Hôpital Saint-Joseph.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Identification of Circulating Tumor Cells TARGET | Identification of Circulating Tumor Cells | Fondation Hôpital Saint-Joseph | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Identification of Circulating Tumor Cells CI watch — RSS
- Identification of Circulating Tumor Cells CI watch — Atom
- Identification of Circulating Tumor Cells CI watch — JSON
- Identification of Circulating Tumor Cells alone — RSS
Cite this brief
Drug Landscape (2026). Identification of Circulating Tumor Cells — Competitive Intelligence Brief. https://druglandscape.com/ci/identification-of-circulating-tumor-cells. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab